Sfoglia per RIVISTA
HEMATOLOGICAL ONCOLOGY
Collezione AOU Novara

  

Items : 18

2025
AOU Novara

Bavieri A; Usai SV; Merli M; Di Rocco A; Cavallo F; Zilioli VR; Zanni M; Leonardo F; Marino D; Arcari A; Cencini E; Gini G; Botto B; Tucci A; Deambrogi C; Caterina P; Paola BM; Hohaus S; Gotti M; Puccini B; Dessì D; Marta C; Petrucci L; Ragaini S; Chimienti E; Marcheselli L; Mammi C; Luminari S; Spina M; et alii...

2025
AOU Novara

Sancetta R; Sanpaolo G; Russo S; Rosati S; Patriarca A; Scortechini AR; Scappini B; Santoro M; De Gobbi M; Miggiano MC; Luciano L; Levato L; Iurlo A; Impera S; Gozzini A; Ferrara F; Genua A; Ermacora A; Ditonno P; Di Veroli A; Crugnola M; Crucitti L; Corsetti MT; Cattina F; Cavazzini F; Carraro MC; Calafiore V; Coco P; Misto A; et alii...

Prescription patterns of venetoclax in acute myeloid leukemia. in Hematological oncology / Hematol Oncol. 2024 Jul;42(4):e3298. doi: 10.1002/hon.3298.

2024
AOU Novara

Patriarca A; Gaidano G; Capelli D; Poloni A; Sciabolacci S; Cardinali V; Pisterna A; Ucciero A; Traversa G; Lunghi M;

2024
AOU Città della Salute di Torino
AOU Novara

Bertuglia G; Franceschini L; Maroccia A; Sgherza N; Reddiconto G; Rizzi R; Gozzetti A; Cotzia E; Bongarzoni V; Rossini B; Fontana R; Amendola A; Amico V; Accardi F; Brunori M; Vincelli ID; Pettine L; Palumbo G; Barilà G; Uccello G; Ria R; Rago A; Tarantini G; Casaluci GM; Offidani M; Di Renzo N; Mele G; Cerchione C; Conticello C; et alii...

Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study. in Hematological oncology / Hematol Oncol. 2024 Jan;42(1):e3216. doi: 10.1002/hon.3216. Epub 2023 Sep 29.

2024
AOU Città della Salute di Torino
AOU Novara

Malgieri S; Molica S; Iannella E; Gozzetti A; Reda G; Caira M; Finsinger P; Gualberti G; Zamprogna G; Coscia M; Albano F; Trentin L; Vallisa D; Pane F; Cuneo A; Mauro FR; Albi E; Chiarenza A; Gaidano G; Sportoletti P; Laurenti L;

2023
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Mammi C; Marcheselli L; Bocchia M; Spina M; Daffini R; Musurca G; Tani M; Nassi L; Merli M; Gini G; Al Essa W; Sartori R; Hohaus S; Botto B; Zanni M; Arcari A; Balzarotti M; Petrucci L; Tafuri A; Marino D; Zilioli VR; Pennese E; Usai SV; Cavallo F; Fabbri A; Puccini B; Luminari S; Tucci A; Cencini E; et alii...

Role of chemotherapy in the treatment of chronic lymphocytic leukemia in the era of targeted therapies in Italy. A Campus CLL network report. in Hematological oncology / Hematol Oncol. 2023 Feb;41(1):201-204. doi: 10.1002/hon.3047. Epub 2022 Aug 19.

2023
AOU Città della Salute di Torino
AOU Novara

Foà R; Moia R; Cuneo A; Reda G; Gottardi D; Chiurazzi F; Orsucci L; Maccaferri M; De Paoli L; Marasca R; Ballotta L;

SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort. in Hematological oncology / Hematol Oncol. 2023 Feb;41(1):128-138. doi: 10.1002/hon.3092. Epub 2022 Oct 25.

2023
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Visco C; Corradini P; Passamonti F; Bertù L; Gherlinzoni F; Pagano L; Guidetti A; Cilloni D; Visani G; Federici AB; Tisi MC; Cudillo L; Galimberti S; Coviello E; Della Porta MG; Mohamed S; Mauro FR; Gentile M; Gambacorti-Passerini C; Massaia M; Bocchia M; Billio A; Cattaneo C; Derenzini E; Scattolin A; Marchesi F; Fracchiolla NS; Arcaini L; Trentin L; et alii...

Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study. in Hematological oncology / Hematol Oncol. 2023 Dec;41(5):877-883. doi: 10.1002/hon.3199. Epub 2023 Jul 1.

2023
AOU Città della Salute di Torino
AOU Novara

Cuneo A; Foà R; Trentin L; Gattei V; Coscia M; Mattiello V; Rigolin GM; Gentile M; Moia R; Scortechini I; Sportoletti P; Catania G; Loseto G; Chiurazzi F; Malerba L; De Paolis MR; Angeletti I; Ferrari A; Giordano A; Baratè C; Quaresmini G; Farina L; Fresa A; Leone MMA; Piciocchi A; Vitale C; Visentin A; Reda G; Innocenti I; et alii...

Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia. in Hematological oncology / Hematol Oncol. 2023 Aug;41(3):567-570. doi: 10.1002/hon.3080. Epub 2022 Oct 10.

2023
AOU Novara

Moia R; Dondolin R; De Propris MS; Talotta D; Mouhssine S; Perutelli F; Reda G; Mattiello V; Rigolin GM; Motta M; Olivieri J; Fanin R; Perbellini O; Ferrarini I; Mauro FR; Del Giudice I; Laurenti L; Tomasso A; Gentile M; Frustaci AM; Tedeschi A; Gozzetti A; Stelitano C; Visco C; Moreno C; Forconi F; Marasca R; Coscia M; Rossi D; et alii...

Long telomeres at baseline and male sex are main determinants of telomere loss following chemotherapy exposure in lymphoma patients. in Hematological oncology / Hematol Oncol. 2023 Aug;41(3):335-342. doi: 10.1002/hon.3118. Epub 2022 Dec 27.

2023
ASL Torino 4
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Tarella C; Avvedimento EV; Pileri S; Cignetti A; Risso A; Bruna R; Gottardi D; Gueli A; Derenzini E;

2022
AOU Novara

Chiattone C; Civallero M; Fischer T; Miranda E; Manni M; Zing NPC; Pileri SA; Montoto S; Horwitz SM; Cabrera ME; De Souza CA; Nagler A; Luminari S; Ferreri AJM; Carson KR; Re A; Rigacci L; Nassi L; Stepanishyna Y; Federico M; Inghirami G;

Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report. in Hematological oncology / Hematol Oncol. 2021 Oct;39(4):570-574. doi: 10.1002/hon.2899. Epub 2021 Jul 13.

2021
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Penna G; Chiarenza A; Foà R; Derenzini E; Levato L; Orsucci L; Gottardi D; Gattei V; Gozzetti A; Gentile M; Sanna A; Olivieri J; Murru R; Stefoni V; Leone M; Baratè C; Marasca R; Malerba L; Ibatici A; Tisi MC; Chiurazzi F; Varettoni M; Del Poeta G; Marchetti M; Farina L; Giordano A; Foglietta M; Re F; De Paoli L; et alii...

Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group. in Hematological oncology / Hematol Oncol. 2021 Aug;39(3):326-335. doi: 10.1002/hon.2861. Epub 2021 Mar 26.

2021
ASL Asti
AOU Città della Salute di Torino
AOU Novara

Foà R; Cuneo A; Vignetti M; Gentile M; Montillo M; Marchetti M; Mauro FR; Crea E; Marasca R; Quaglia FM; Laurenti L; Molinari AL; Paolini R; Pietrasanta D; Sportoletti P; Varettoni M; Farina L; Murru R; Gaidano G; Cibien F; Vitagliano O; Coscia M; Zamprogna G; Visentin A; Reda G; Arena V; Cavazzini F; Piciocchi A; Rigolin GM; et alii...

Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients. in Hematological oncology / Hematol Oncol. 2020 Aug;38(3):406-408. doi: 10.1002/hon.2722. Epub 2020 Feb 25.

2020
AOU Novara

Lionetti M; Barbieri M; Favasuli V; Taiana E; Fabris S; Favoino C; Ciceri G; Matis S; Colombo M; Massara R; Reda G; Gentile M; Spina V; Rossi D; Baldini L; Gaidano G; Fais F; Ferrarini M; Morabito F; Cutrona G; Neri A;

Anti-rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity. in Hematological oncology / Hematol Oncol. 2020 Apr;38(2):204-206. doi: 10.1002/hon.2700. Epub 2020 Jan 27.

2020
AOU Novara

Moia R; Boggio E; Gigliotti L; Crisà E; De Paoli L; Margiotta Casaluci G; Rolla R; Patriarca A; Gaidano G; Dianzani U; Bruna R;

Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals. in Hematological oncology / Hematol Oncol. 2018 Dec;36(5):757-764. doi: 10.1002/hon.2536. Epub 2018 Aug 16.

2018
AOU Novara

Conconi A; Zucca E; Margiotta-Casaluci G; Darling K; Hasse B; Battegay M; Staehelin C; Novak U; Schmid P; Scherrer A; Dirnhofer S; Kwee I; Nassi L; Cavalli F; Gaidano G; Bertoni F; Bernasconi E;

Richter syndrome: molecular insights and clinical perspectives. in Hematological oncology / Hematol Oncol. 2009 Mar;27(1):1-10. doi: 10.1002/hon.880.

2009
AOU Novara

Rossi D; Gaidano G;